Loading...

LRMR - Larimar Therapeutics, Inc.

Overbought Signal for 02-15-2024
Overbought Stock Signal: LRMR


Loading Chart LRMR

Stock Signal Information


Signal

Overbought Stock Signal: LRMR
Report Date: 02-15-2024
Symbol: LRMR - Larimar Therapeutics, Inc.
Sector:
Industry:
Overbought Stock Signal: LRMR

  LRMR Technical Analysis

Company Contact

Larimar Therapeutics, Inc. (LRMR)
THREE BALA PLAZA EAST. SUITE 506
Bala Cynwyd, PENNSYLVANIA 19004
Phone: 18445119056
Website: https://www.larimartx.com
CEO: Dr. Carole S. Ben-Maimon

LRMR, Larimar Therapeutics, Inc.

LRMR Larimar Therapeutics, Inc. Logo Image

NASDAQ, Nasdaq Global Select


Company Profile

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare and progressive genetic disease. Larimar Therapeutics, Inc. is headquartered in Bala Cynwyd, Pennsylvania.